EntomoPharm was founded in 2009 by Peter Aadal Nielsen, M.Sc., PhD and Gunnar Andersson, M.Sc., PhD and uses Grasshoppers to develop cutting-edge ex vivo screening model for pre-clinical ADMET testing.

Their vision came to fruition with an initial investment from SydDansk Teknologisk Innovation that allowed them to patent and test the first ever insect models.